Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. The therapeutic potential of microRNAs to ameliorate spinal cord injury by regulating oligodendrocyte progenitor cells and remyelination

The therapeutic potential of microRNAs to ameliorate spinal cord injury by regulating oligodendrocyte progenitor cells and remyelination

Frontiers in Cellular Neuroscience, 2024 · DOI: 10.3389/fncel.2024.1404463 · Published: May 15, 2024

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

Spinal cord injury (SCI) can cause loss of sensory and motor function below the level of injury, posing a serious threat to human health and quality of life. One significant characteristic feature of pathological changes following injury in the nervous system is demyelination, which partially contributes to the long-term deficits in neural function after injury. The remyelination in the central nervous system (CNS) is mainly mediated by oligodendrocyte progenitor cells (OPCs).

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review

Key Findings

  • 1
    miRNAs can modulate axon outgrowth, inflammation, angiogenesis, apoptosis, astrogliosis, and remyelination after SCI.
  • 2
    Administration of miR-219 agomiR in rats after unilateral C5 contusion SCI significantly promoted OPC differentiation, increased OL number, enhanced myelin repair, and partially improved the forelimb motor function
  • 3
    miR-125a-3p might hinder the repairment of demyelinating lesions and exacerbate the development of MS by blocking OPC differentiation

Research Summary

This review focuses on the demyelination and remyelination after SCI, and summarizes the progress of miRNAs on OPC functions and remyelination, which might provide a potential therapeutic target for SCI treatments. SCI activates the OPCs around the lesion, which then turn into a bipolar migratory shape and alter gene expression, preparing for the following proliferation and differentiation. In general, in this review, we focus on remyelination after SCI and summarize miRNAs that can regulate OPC functions, which might be used for SCI treatments.

Practical Implications

Therapeutic Target for SCI

miRNAs regulating OPC function offer a potential therapeutic avenue for SCI treatment by enhancing remyelination.

Delivery Method Improvement

Efficient delivery methods for miRNA-based therapies are needed to improve stability and tissue penetration in vivo.

Functional Recovery

Promoting remyelination through miRNA modulation can lead to improved functional recovery after SCI.

Study Limitations

  • 1
    Delivery challenges of miRNAs
  • 2
    Stability of miRNAs in vivo
  • 3
    Potential immune responses to miRNA therapies

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury